2023年7月17日 · A RAD51D mutation increases your risk for ovarian cancer. A RAD51D mutation may also increase your risk for breast cancer, but more research is needed for us to better …

2024年9月6日 · Read about the latest expert guidelines for cancer screening and prevention for people with a RAD51D mutation. Learn about research studies enrolling high-risk patients.

2024年9月22日 · Women with a RAD51D mutation have about a 10-20 percent lifetime risk for ovarian, fallopian tube or primary peritoneal cancer (these three cancers and their risks are …

2024年12月25日 · RAD51D (RAD51 Paralog D) is a Protein Coding gene. Diseases associated with RAD51D include Breast-Ovarian Cancer, Familial 4 and Hereditary Breast Ovarian …

2024年9月2日 · People with a RAD51D mutation may have different options for cancer treatment. Learn about the treatment options for people with mutations in this gene. FORCE is here to …

RAD51D Mutation is a predictive biomarker for use of olaparib in patients. Of the therapies with RAD51D Mutation as a predictive biomarker, 1 is FDA-approved and 1 has NCCN guidelines …

Here, we have reviewed the landscape of RAD51C and RAD51D germline variants in cancer reported in the literature during the last decade, integrating this list with variants identified by in …

RAD51D is primarily a moderate penetrance susceptibility gene for ovarian cancer, with clinical significance for the carriers. The RAD51D should be included in genetic screening of ovarian …

RAD51 is central to DNA damage repair in the HR pathway. As such, understanding the function and regulation of RAD51 is essential for cancer biology. This review will focus on the role of …

Women who have a pathogenic or likely pathogenic variant (sometimes called a mutation) in the RAD51D gene have a higher-than-average chance to develop ovarian cancer and possibly …